6,7,8,9-Tetrahydrospiro[benzo[7]annulene-5,4'-imidazolidine]-2',5'-dione, 95+%, 100mg

tert-Butyl (4R,6R)-2-[6-[2-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxan-4-yl]acetate>98.0%(HPLC)(N)5g

2-Boc-amino-1-(4-carbamoyl-piperazin-1-yl)-ethanone, 98.0%, 1g

Barreaux magnétiques ROTILABO® avec anneau central, , 8 mm, 25 mm, jaune, 1 pièce

Benzonitrile, 2-[[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]methyl]-, 95%, 1g

1-Acetylpiperidine-4-carboxylic acid, 98.0%, 5g

(S)-Octahydropyrazino[2,1-c][1,4]oxazine dihydrochloride, 95.0%, 1g

2-Amino-6-bromo-3-fluorobenzoic acid, 95.0%, 10g

3-Oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-7-carboxylic acid, 95%, 1g

Acide diéthylènetriaminepentaacétique, min 99%, pour la synthèse, 1 kg, emballage plastique.

3-Chloro-6-pyrrolidin-1-yl-pyridazine, 95.0%, 25g

tert-butyl 5,5-difluoro-2,7-diazaspiro[3.5]nonane-2-carboxylate, 95.0%, 10g

2-Chloro-4-nitrobenzaldehyde, 98%, 1g